metoprolol alvogen (metoprolol ratiopharm) forðatafla 23,75 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 23,75 mg
metoprolol alvogen (metoprolol ratiopharm) forðatafla 47,5 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 47,5 mg
zeposia
bristol-myers squibb pharma eeig - ozanimod stutt og long-term - multiple sclerosis, relapsing-remitting; colitis, ulcerative - Ónæmisbælandi lyf - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
duta tamsaxiro hart hylki 0,5/0,4 mg
medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
duodart hart hylki 0,5/0,4 mg
glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
dutaprostam hart hylki 0,5/0,4 mg
zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
dutasteride/tamsulosin teva (dutasteride/tamsulosinehydrochloride teva) hart hylki 0,5 mg/0,4 mg
teva b.v.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5 mg/0,4 mg
relpax filmuhúðuð tafla 40 mg
upjohn eesv - eletriptanum brómíð - filmuhúðuð tafla - 40 mg
tamsulosin medical (tamsulijn) hart hylki með breyttan losunarhraða 0,4 mg
medical ehf. - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg
tamsulosin viatris (tamsulosin mylan 0,4 mg hart hylki með breyttan losunarhraða) hart hylki með breyttan losunarhraða 0,4 mg
viatris limited - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg